NewMed Ltd Wins Best PEMF Therapy Products 2025 Award

NewMed Ltd, a UK-based provider of innovative PEMF devices, is proud to announce that it has been awarded Best PEMF Therapy Products 2025 by Acquisition International Magazine as part of their Global Excellence Awards. This recognition highlights NewMed Ltd’s ongoing dedication to supporting health and wellbeing through high-quality PEMF technology.

For nearly a decade, NewMed has played a key role in the UK PEMF industry, offering a broad range of devices for both professional and at-home use. In addition to supplying devices, NewMed has developed several platforms to educate and guide customers on their PEMF journey, including The PEMF Podcast, where listeners can explore expert insights and hear real-life experiences.

In recent years, NewMed Ltd has used its expertise to develop its own PEMF brand, CELLER8®. Designed by Founder, Andy Smith, CELLER8® combines modern technology with ease of use, portability, and clear, science-informed features. Since its launch, CELLER8® has gained attention at wellness and biohacking exhibitions and has quickly become a popular choice among health conscious users.

Andy Smith, Managing Director at NewMed Ltd and founder of CELLER8®, commented:
"The team and I are thrilled to have received the Best PEMF Therapy Products 2025 award. To be recognised by Acquisition International is a huge honour and a testament to the hard work and dedication of everyone at NewMed. We’re passionate about making PEMF more widely understood and accessible, and this award inspires us to keep innovating and educating in this exciting field."

This recognition reflects NewMed Ltd’s continued growth within the wellness sector and its mission to make PEMF technology more accessible and trusted across the UK and beyond.